These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 19004667)

  • 1. Effects of phosphodiesterase-5 inhibition by sildenafil in the pressure overloaded right heart.
    Andersen A; Nielsen JM; Peters CD; Schou UK; Sloth E; Nielsen-Kudsk JE
    Eur J Heart Fail; 2008 Dec; 10(12):1158-65. PubMed ID: 19004667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of cyclic guanylate cyclase stimulation on right ventricular hypertrophy and failure alone and in combination with phosphodiesterase-5 inhibition.
    Andersen A; Nielsen JM; Holmboe S; Vildbrad MD; Nielsen-Kudsk JE
    J Cardiovasc Pharmacol; 2013 Aug; 62(2):167-73. PubMed ID: 23575263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
    Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
    Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sildenafil prevents and reverses transverse-tubule remodeling and Ca(2+) handling dysfunction in right ventricle failure induced by pulmonary artery hypertension.
    Xie YP; Chen B; Sanders P; Guo A; Li Y; Zimmerman K; Wang LC; Weiss RM; Grumbach IM; Anderson ME; Song LS
    Hypertension; 2012 Feb; 59(2):355-62. PubMed ID: 22203744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of phosphodiesterase 5 inhibition in pulmonary hypertension are influenced by natriuretic Peptide activity.
    Zhao L; Mason NA; Strange JW; Walker H; Wilkins MR
    Circulation; 2003 Jan; 107(2):234-7. PubMed ID: 12538421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sildenafil treatment in established right ventricular dysfunction improves diastolic function and attenuates interstitial fibrosis independent from afterload.
    Borgdorff MA; Bartelds B; Dickinson MG; van Wiechen MP; Steendijk P; de Vroomen M; Berger RM
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H361-9. PubMed ID: 24878769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho kinase mediates right ventricular systolic dysfunction in rats with chronic neonatal pulmonary hypertension.
    Gosal K; Dunlop K; Dhaliwal R; Ivanovska J; Kantores C; Desjardins JF; Connelly KA; McNamara PJ; Jain A; Jankov RP
    Am J Respir Cell Mol Biol; 2015 Jun; 52(6):717-27. PubMed ID: 25337652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.
    Yin J; Kukucka M; Hoffmann J; Sterner-Kock A; Burhenne J; Haefeli WE; Kuppe H; Kuebler WM
    Circ Heart Fail; 2011 Mar; 4(2):198-206. PubMed ID: 21216837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin receptor blockade combined with phosphodiesterase-5 inhibition increases right ventricular mitochondrial capacity in pulmonary arterial hypertension.
    Mouchaers KT; Schalij I; Versteilen AM; Hadi AM; van Nieuw Amerongen GP; van Hinsbergh VW; Postmus PE; van der Laarse WJ; Vonk-Noordegraaf A
    Am J Physiol Heart Circ Physiol; 2009 Jul; 297(1):H200-7. PubMed ID: 19395550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right ventricular cyclic nucleotide signaling is decreased in hyperoxia-induced pulmonary hypertension in neonatal mice.
    Heilman RP; Lagoski MB; Lee KJ; Taylor JM; Kim GA; Berkelhamer SK; Steinhorn RH; Farrow KN
    Am J Physiol Heart Circ Physiol; 2015 Jun; 308(12):H1575-82. PubMed ID: 25862831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin and sildenafil combine to attenuate pulmonary hypertension.
    Zhao L; Sebkhi A; Ali O; Wojciak-Stothard B; Mamanova L; Yang Q; Wharton J; Wilkins MR
    Eur Respir J; 2009 Oct; 34(4):948-57. PubMed ID: 19797670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats.
    Lang M; Kojonazarov B; Tian X; Kalymbetov A; Weissmann N; Grimminger F; Kretschmer A; Stasch JP; Seeger W; Ghofrani HA; Schermuly RT
    PLoS One; 2012; 7(8):e43433. PubMed ID: 22912874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil.
    Mouchaers KT; Schalij I; de Boer MA; Postmus PE; van Hinsbergh VW; van Nieuw Amerongen GP; Vonk Noordegraaf A; van der Laarse WJ
    Eur Respir J; 2010 Oct; 36(4):800-7. PubMed ID: 20351034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
    Botha P; Parry G; Dark JH; Macgowan GA
    J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sildenafil on pulmonary hypertension and levels of ET-1, eNOS, and cGMP in aorta-banded rats.
    Dai ZK; Tan MS; Chai CY; Chou SH; Lin PC; Yeh JL; Jeng AY; Chang CI; Chen IJ; Wu JR
    Exp Biol Med (Maywood); 2006 Jun; 231(6):942-7. PubMed ID: 16741028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antenatal sildenafil treatment attenuates pulmonary hypertension in experimental congenital diaphragmatic hernia.
    Luong C; Rey-Perra J; Vadivel A; Gilmour G; Sauve Y; Koonen D; Walker D; Todd KG; Gressens P; Kassiri Z; Nadeem K; Morgan B; Eaton F; Dyck JR; Archer SL; Thébaud B
    Circulation; 2011 May; 123(19):2120-31. PubMed ID: 21537000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac anti-remodelling effects of phosphodiesterase type 5 inhibitors: afterload-(in)dependent?
    Kuhn M
    Cardiovasc Res; 2009 Apr; 82(1):4-6. PubMed ID: 19221131
    [No Abstract]   [Full Text] [Related]  

  • 18. PDE5A inhibition attenuates bleomycin-induced pulmonary fibrosis and pulmonary hypertension through inhibition of ROS generation and RhoA/Rho kinase activation.
    Hemnes AR; Zaiman A; Champion HC
    Am J Physiol Lung Cell Mol Physiol; 2008 Jan; 294(1):L24-33. PubMed ID: 17965319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects of ANP and sildenafil on cGMP levels and amelioration of acute hypoxic pulmonary hypertension.
    Preston IR; Hill NS; Gambardella LS; Warburton RR; Klinger JR
    Exp Biol Med (Maywood); 2004 Oct; 229(9):920-5. PubMed ID: 15388887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sildenafil enhances systolic adaptation, but does not prevent diastolic dysfunction, in the pressure-loaded right ventricle.
    Borgdorff MA; Bartelds B; Dickinson MG; Boersma B; Weij M; Zandvoort A; Silljé HH; Steendijk P; de Vroomen M; Berger RM
    Eur J Heart Fail; 2012 Sep; 14(9):1067-74. PubMed ID: 22730335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.